Tenet Healthcare (NYSE:THC) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Tenet Healthcare (NYSE:THC) from a buy rating to a strong-buy rating in a research report report published on Monday morning.

A number of other equities research analysts have also issued reports on the stock. Barclays upped their target price on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research note on Friday, July 24th. KeyCorp lowered their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Guggenheim upped their price objective on Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. Truist Financial lifted their target price on Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a research report on Tuesday, July 28th. Finally, Piper Sandler set a $308.00 price target on Tenet Healthcare in a research report on Monday, July 27th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $271.00.

Tenet Healthcare Price Performance

THC stock opened at $262.20 on Monday. The company has a market capitalization of $22.59 billion, a PE ratio of 10.11, a P/E/G ratio of 0.96 and a beta of 1.23. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The stock’s 50 day moving average is $196.78 and its two-hundred day moving average is $200.54. Tenet Healthcare has a 52-week low of $157.58 and a 52-week high of $263.60.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same quarter in the previous year, the firm earned $4.02 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare will post 21.09 earnings per share for the current fiscal year.

Insider Transactions at Tenet Healthcare

In related news, Director Christopher S. Lynch sold 3,837 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $243.44, for a total value of $934,079.28. Following the sale, the director owned 9,568 shares of the company’s stock, valued at approximately $2,329,233.92. This trade represents a 28.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nadja West sold 3,000 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 33,353 shares of company stock valued at $7,683,517 over the last ninety days. Insiders own 0.97% of the company’s stock.

Institutional Trading of Tenet Healthcare

A number of large investors have recently modified their holdings of the company. Wedge Capital Management L L P NC lifted its position in Tenet Healthcare by 37.6% in the 2nd quarter. Wedge Capital Management L L P NC now owns 221,453 shares of the company’s stock valued at $41,429,000 after purchasing an additional 60,478 shares during the last quarter. Polianta Ltd acquired a new stake in shares of Tenet Healthcare in the second quarter valued at approximately $2,001,000. Gradient Investments LLC bought a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $1,630,000. Baron Wealth Management LLC boosted its position in shares of Tenet Healthcare by 15.6% during the second quarter. Baron Wealth Management LLC now owns 1,289 shares of the company’s stock worth $241,000 after buying an additional 174 shares during the period. Finally, BDF Gestion bought a new position in Tenet Healthcare in the 2nd quarter worth approximately $1,673,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.